According to related industries, U.S.-Moderna Korea and Chinese-BeiGene Korea recently joined as KRPIA members. As a result, the number of KRPIA member companies has increased to 46.

Both Moderna and BeiGene are multinational pharmaceutical companies that established a Korean subsidiary last year, and promotional activities are expected to begin in earnest this year. Moderna, well-known as a developer of the COVID-19 vaccine, recruited Son Ji-young, former CEO of CSL Behring Korea, as the first corporate president at the end of last year. The company is currently taking three strategies: ▲ High-capacity booster shots ▲ New booster shots ▲ Omicron-specific booster shots to cope with some variations in